SOURCE: PacerView Technologies, LLC

January 25, 2010 12:33 ET

PacerView Technologies Sells Innovative Catheter Placement Technology

SAN CLEMENTE, CA--(Marketwire - January 25, 2010) - PacerView Technologies, LLC, a California medical technologies company, has sold substantially all of its assets related to its PacerView™ technology to Bard Access Systems, Inc. ("Bard").

The PacerView™ technology -- created by Dr. Peter M. Rothenberg -- is intended to facilitate central venous catheter placement following characteristic changes in an electrocardiogram.

"I am excited to connect this technology with a company like Bard," said Dr. Rothenberg. "The medical system is under increased pressure to do more procedures for more people. However, reimbursements are generally decreasing while costs are increasing. A technology that could potentially save time and money with improved efficiency and accuracy would be a win-win for clinicians, patients and the medical system."

Davis Wright Tremaine LLP advised PacerView Technologies on the transaction.

About PacerView Technologies

PacerView Technologies, LLC is a medical technologies company committed to improving the success and efficiency of medical care, specializing in electrocardiographic localization of catheter tips. The company was founded in 2008 by Peter M. Rothenberg, MD, MA, a board certified intensivist. Following college, Dr. Rothenberg earned his Master's degree in experimental physiological psychology from the Ferkauf Graduate School of Yeshiva University with a research fellowship at The Rockefeller University. Continuing his research in medical school with fellowships at the National Cancer Institute and National Institute for Mental Health, he went on to graduate The George Washington University School of Medicine "With Distinction" and was elected to the Alpha Omega Alpha National Medical Honor Society. He has been practicing Internal and Critical Care Medicine since. He is a joint inventor on a patented device that facilitates bedside display of an intravascular cardiac signal and is the sole inventor on 3 more patent pending applications.

Contact Information

  • Media Contact:
    Peter M. Rothenberg, M.D., M.A.
    949 489-9039
    Email Contact